quinuclidines has been researched along with Drug Withdrawal Symptoms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blendy, JA; Turner, JR; Yohn, NL | 1 |
Connor, DA; Gould, TJ; Yildirim, E | 1 |
Chu, LF; Clark, JD; D'Arcy, N; Encisco, EM; Erlendson, MJ; Peltz, G; Rincon-Cruz, L; Yu, JJ | 1 |
Eriksson, B; Nordberg, A; Wahlström, G | 1 |
1 trial(s) available for quinuclidines and Drug Withdrawal Symptoms
Article | Year |
---|---|
Palonosetron and hydroxyzine pre-treatment reduces the objective signs of experimentally-induced acute opioid withdrawal in humans: a double-blinded, randomized, placebo-controlled crossover study.
Topics: Cross-Over Studies; Double-Blind Method; Drug Synergism; Healthy Volunteers; Humans; Hydroxyzine; Isoquinolines; Male; Morphine; Naloxone; Palonosetron; Quinuclidines; Substance Withdrawal Syndrome; Young Adult | 2017 |
3 other study(ies) available for quinuclidines and Drug Withdrawal Symptoms
Article | Year |
---|---|
Activation of α4β2*/α6β2* nicotinic receptors alleviates anxiety during nicotine withdrawal without upregulating nicotinic receptors.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Brain; Drug Partial Agonism; Indoles; Male; Mice; Nicotine; Nicotinic Agonists; Pyridines; Pyrrolidines; Quinuclidines; Radioligand Assay; Receptors, Nicotinic; Substance Withdrawal Syndrome; Time Factors; Up-Regulation | 2014 |
ABT-089, but not ABT-107, ameliorates nicotine withdrawal-induced cognitive deficits in C57BL6/J mice.
Topics: Animals; Cognition; Conditioning, Psychological; Cues; Dose-Response Relationship, Drug; Drug Partial Agonism; Fear; Hippocampus; Indoles; Learning; Male; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Pyridines; Pyrrolidines; Quinuclidines; Receptors, Nicotinic; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2015 |
Relations between muscimol, quinuclidinyl benzilate and nicotine binding sites in brain after very long treatment with ethanol in rats.
Topics: Animals; Brain Chemistry; Cerebral Cortex; Ethanol; Kinetics; Male; Muscimol; Quinuclidines; Quinuclidinyl Benzilate; Rats; Rats, Inbred Strains; Receptors, Nicotinic; Substance Withdrawal Syndrome; Time Factors | 1985 |